|

HX009+IN10018 Clinical Trials

1 actively recruiting trial

Pipeline

Phase 1/2: 1

Top Sponsors

  • Hangzhou Hanx Biopharmaceuticals, Ltd.1

Indications

  • Biliary Tract Cancer1
  • Melanoma1
  • Cancer1

Other1 trial

HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours
Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.